GlassScriptPhysician profile
Michael George Nagle
NPI 1699717132
$1,310.47
in general payments reported to CMS, 2019-2025
10 companies · $52.28 in 2025
The $52.28 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
See the full distribution for Undersea and Hyperbaric Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $12.90 · 2021: $88.62 · 2022: $134 · 2023: $20.42 · 2024: $37.12 · 2025: $52.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $866.02 | 2019 | |
| Organogenesis INC. | $184.29 | 2019-2025 | Apligraf, Puraply Wound Matrix |
| Urgo Medical North America, LLC | $91.35 | 2022 | |
| Kci USA, INC. | $51.49 | 2021-2022 | |
| Smith+Nephew, INC. | $40.87 | 2023-2024 | Pico 7, Grafix |
| Integra Lifesciences Corporation | $21.58 | 2021 | |
| Cook Medical LLC | $16.90 | 2025 | Zenith Spiral-Z |
| Aroa Biosurgery Incorporated | $12.90 | 2020 | |
| Molnlycke Health Care US, LLC | $12.82 | 2021 | |
| Acera Surgical, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.